JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhao, X.-J.
Right arrow Articles by Poyton, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhao, X.-J.
Right arrow Articles by Poyton, R. O.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 41, Issue of October 11, 1996 pp. 25131-25138
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Function and Expression of Flavohemoglobin in Saccharomyces cerevisiae
EVIDENCE FOR A ROLE IN THE OXIDATIVE STRESS RESPONSE*

(Received for publication, May 2, 1996, and in revised form, July 8, 1996)

Xiao-Jian Zhao Dagger , Desmond Raitt §, Patricia V. Burke , Amy S. Clewell , Kurt E. Kwast and Robert O. Poyton par

From the Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, Colorado 80309-0347

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

We have studied the function and expression of the flavohemoglobin (YHb) in the yeast Saccharomyces cerevisiae. This protein is a member of a family of flavohemoproteins, which contain both heme and flavin binding domains and which are capable of transferring electrons from NADPH to heme iron. Normally, actively respiring yeast cells have very low levels of the flavohemoglobin. However, its intracellular levels are greatly increased in cells in which the mitochondrial electron transport chain has been compromised by either mutation or inhibitors of respiration. The expression of the flavohemoglobin gene, YHB1, of S. cerevisiae is sensitive to oxygen. Expression is optimal in hyperoxic conditions or in air and is reduced under hypoxic and anaerobic conditions. The expression of YHB1 in aerobic cells is enhanced in the presence of antimycin A, in thiol oxidants, or in strains that lack superoxide dismutase. All three conditions lead to the accumulation of reactive oxygen species and promote oxidative stress. To study the function of flavohemoglobin in vivo, we created a null mutation in the chromosomal copy of YHB1. The deletion of the flavohemoglobin gene in these cells does not affect growth in either rhoo or rho+ genetic backgrounds. In addition, a rho+ strain carrying a yhb1- deletion has normal levels of both cyanide-sensitive and cyanide-insensitive respiration, indicating that the flavohemoglobin does not function as a terminal oxidase and is not required for the function or expression of the alternative oxidase system in S. cerevisiae. Cells that carry a yhb1-deletion are sensitive to conditions that promote oxidative stress. This finding is consistent with the observation that conditions that promote oxidative stress also enhance expression of YHB1. Together, these findings suggest that YHb plays a role in the oxidative stress response in yeast.


INTRODUCTION

Hemoglobins, defined as hemoproteins that bind oxygen reversibly, have been detected in a wide range of organisms including vertebrates, invertebrates, higher plants, fungi, and bacteria (1, 2). Although all of these hemoglobins have a conserved heme binding domain, the ``myoglobin fold,'' they are otherwise divergent in both structure and complexity (2). Whereas most vertebrate hemoglobins are composed of two types of polypeptide subunits, alpha  and beta , which have single heme domains and form alpha 2beta 2 tetramers, invertebrate and microbial hemoglobins are more varied. For example, the bacterial and fungal hemoglobins that have been characterized to date fall into two general categories: dimeric hemoproteins composed of two single heme domain polypeptides and monomeric flavohemoproteins composed of a single polypeptide containing a single heme binding domain and a single flavin binding domain. The first type of hemoglobin (VGB) is present in the bacterium Vitreoscilla (3). This protein has partial primary sequence similarity to plant leghemoglobin (3). The second type of hemoglobin has been found in the bacteria Escherichia coli (4, 5, 6) and Alcaligenes eutrophus (7) and in the fungi Candida norvensis (8) and Saccharomyces cerevisiae (9, 10). The N-terminal regions of these proteins bind heme and have primary sequence homology to VGB and plant leghemoglobin (2, 10). The C-terminal region has an FAD-binding domain and is related to proteins in the ferredoxin-NADP+ reductase (FNR) family (11). A third type of hemoglobin is found in protozoa (Paramecium caudatum, Tetrahymena pyriformis, and Tetrahymena thermophila) and the cyanobacterium, Nostoc commune (12). This is a single heme domain polypeptide that is considerably smaller than the other two types of microbial hemoglobins discussed above. Although the hemoglobins from protozoa and Nostoc have primary sequence similarity with one another, they show no significant sequence similarities with other hemoglobins. Like microbial hemoglobins, the hemoglobins of invertebrates are also extremely diverse (2). They fall into four categories: 1) single-heme domain single subunit hemoglobins (~16 kDa); 2) two-heme domain subunits that assemble into multi-subunit complexes (250-800 kDa); 3) multi-heme domain subunits that assemble into multi-subunit complexes (240-8,000 kDa); and 4) single-heme domain multi-subunit complexes in which some of the polypeptide chains are disulfide linked (2).

Although the function of vertebrate hemoglobins and myoglobin in oxygen binding and diffusion is well established, the function(s) of hemoglobins in other groups of organisms is unclear. Several possible functions have been proposed. For example, Vitreoscilla hemoglobin has been proposed to function in oxygen storage, diffusion, or delivery in cells grown at low oxygen partial pressures (3, 13, 14). In addition, it can serve as a terminal oxidase under some conditions (15). The flavohemoglobin FHP of A. eutrophus has been proposed to function, either directly or indirectly, in nitrate respiration (16). And the flavohemoglobin HMP of E. coli has been proposed to be an oxygen sensor (17, 18).

In this study we have addressed the physiological role of the flavohemoglobin (YHb) of S. cerevisiae. This protein binds oxygen reversibly only when NADPH is present, indicating that it has an NAD(P)H reductase activity for the heme domain (19, 20). Respiring S. cerevisiae cells normally have very low levels of YHb. However, its intracellular levels are greatly increased in cells in which the mitochondrial electron transport chain has been compromised by either mutation (i.e. the deletion of the mitochondrial genome) (21) or respiration inhibitors (e.g. antimycin A) (10, 22). Its level also increases in cells engineered to express the hypoxic isoform, Vb, of cytochrome c oxidase subunit V under aerobic conditions (21). Here, by combining studies on the expression of YHB1, the structural gene for YHb, with studies on mutant yeast strains that lack YHb we have obtained evidence for a role for YHb in the oxidative stress response in yeast.


EXPERIMENTAL PROCEDURES

Yeast Strains, Plasmids, and Growth Conditions

The following strains of S. cerevisiae were used: JM43 (MATalpha his4-580 trp1-289 leu2-3, 112 ura3-52 [rho+]) (23); JM43rho o, a respiratory-deficient derivative of JM43 that lacks a functional mitochondrial genome (21); DR11, a derivative of JM43 containing a URA3 disrupted YHB1 gene; DR10, a derivative of JM43rho o containing a URA3 disrupted YHB1 gene; EG103 (MATalpha leu2-3, 112 his3Delta 1 trp1-289a ura3-52); and EG133, a derivative of EG103 containing a URA3 disrupted SOD1 gene and a TRP1 disrupted SOD2 gene. EG103 and EG133 were kindly provided by Dr. E. Gralla (24). The original plasmid, pYHB4, containing the YHB1 gene was kindly supplied by Drs. H. Zhu and A. Riggs (10).

Strains DR11 and DR10 were constructed using the one-step gene disruption technique (25) as follows. A 4-kb1 BamHI genomic fragment from plasmid pYHB4, which contains the YHB1 gene and flanking sequences, was cloned into the unique BamHI site of pBR322 (26). This vector was then digested with HindIII, which removed 300 bp of the coding region just downstream of the heme binding domain of YHB1 gene. The URA3 gene, isolated as a 1.1-kb HindIII fragment from YEp24 (27), was cloned into the HindIII-digested vector. The resulting plasmid, pDR103, contains the URA3 gene in place of 300 bp of the yeast hemoglobin coding sequence. A 5.1-kb BamHI fragment containing the disrupted YHB1 gene was isolated from pDR103, gel purified, and then used to transform JM43 and JM43rho o to Ura+ prototrophy by the lithium acetate procedure (28). Several Ura+ transformants were selected and subjected to Southern blot analysis to confirm the disruption of the YHB1 gene. One transformant of JM43 and one of JM43rho o were saved for analysis. Both the DNA fragment used for transformation and the probe fragment used to confirm the disruption are shown in Fig. 1A. The high copy plasmid pFL46s-YHB1 was constructed by inserting the 4-kb BamHI restriction fragment containing YHB1 into the vector pFL46s (29).


Fig. 1. Gene disruption of the chromosomal copy of YHB1. A gene disruption of YHB1 was constructed as described under ``Experimental Procedures.'' A, schematic diagram of the chromosomal locus of the parent strain JM43 and the location of the URA3 gene insertion in the yhb1::URA3 gene disruption strain DR11. The restriction sites, BamHI (B), HindIII (H), and BglII (Bg), are shown. The 300-bp cross-hatched HindIII fragment was removed and replaced by a 1.1-kb HindIII fragment containing the URA3 gene. The shaded region represents the YHB1 coding region, and the direction of transcription is shown by the arrow. B, Southern blot analysis of genomic DNA from JM43 and DR11. Genomic DNA was digested with BamHI and probed with the BglII-HindIII probe shown in A.
[View Larger Version of this Image (14K GIF file)]

Liquid cultures were grown at 28-30 °C with shaking (200 rpm) in YPGal (1% yeast extract, 2% Bacto-peptone, 2% galactose) or YPD (1% yeast extract, 2% Bacto-peptone, 2% glucose). For experiments with different gas mixtures cells were grown in SSG (per liter: 3 g of yeast extract, 10 g of galactose, 0.8 g of NH4SO4, 1 g of KH2PO4, 0.5 g of NaCl, 0.7 g of MgSO4·7H2O, 5 µg of FeCl2, 0.4 g of CaCl2) supplemented with 1.0% Tween 80, 20 µg/ml ergosterol, 350 ppm Dow Corning FG-10 silicone antifoam, and amino acids and uracil at 40 µg/ml in a New Brunswick Bioflo IIc fermentor using either air, nitrogen (O2-free nitrogen containing 2.5% CO2), or 95% oxygen (brought to volume with 5% nitrogen) as the sparge gas. Medium was solidified with 2% agar as appropriate.

Difference Spectroscopy

Reduced, carbon monoxide (CO)-ligated, and oxidized whole cell suspensions for the reduced minus CO-ligated and reduced minus oxidized difference spectra were prepared as follows. A concentrated cell suspension (typically 0.45 g of wet weight/ml of whole yeast cells) was adjusted to 1% (w/v) glucose in a sealed, small test tube and incubated without agitation for 5 min at room temperature to achieve anaerobiosis. An aliquot (1 ml) of the reduced cell suspension was then transferred into a spectrophotometer cuvette. The cuvette was sealed with a rubber stopper and parafilm. The sample was incubated in the cuvette for an additional 5 min at room temperature to ensure that any oxygen that may have diffused into the sample during transfer was reduced. The CO-ligated sample was prepared by adding antifoam (Dow Corning FG-10, 100 ppm) to the reduced cell suspension and bubbling very slowly with CO gas (99.5%) for 5 min. The oxidized sample was prepared by adding 25 µl of 30% H2O2 to 1 ml of the reduced sample in the cuvette and incubating the sample at room temperature for 2 min. All spectra were recorded using a SLM AMINCO DW2000 dual wavelength scanning UV-visible spectrophotometer (SLM Instruments, Inc.) with the reference monochromator set to a wavelength of 577 nm.

Determination of Drug Resistance

Yeast strains were grown in liquid YPGal to log phase, plated onto YPD containing various concentrations of drugs, and grown at 28 °C for 3 (H2O2 and paraquat) or 5 days (diethylmaleate and diamide). In another experiment, the yeast strains were grown in YPD, plated with various concentrations of paraquat, and cultured under hyperoxic conditions (95% O2 and 5% N2) for 3 days at room temperature.

Induction of YHB1

To study the transcriptional induction of YHB1 by oxidative stress inducing drugs, JM43 was grown in YPGal to log phase and pelleted. The yeast cells were then resuspended in the same volume of fresh YPGal, aliquoted, and incubated for 1 h with the appropriate drug. Total RNA was prepared as described previously (30).

Northern Blotting

For Northern analysis, RNA samples (30 µg) were separated on 1.5% agarose gels containing 0.22 M formaldehyde (31), transferred to a Schleicher & Schuell Nytran membrane, and hybridized according to the manufacturer's suggestions. DNA probes were prepared by random-primer labeling of double stranded DNA fragments using [alpha -32P]dCTP (32). Probes were a 600-bp SspI fragment for YHB1, a 500-bp StyI fragment for ACT1 (the gene encoding actin), a 500-bp PstI fragment for COX5a (the gene encoding the Va isoform of subunit V of cytochrome c oxidase), and a 370-bp AccI/BglII fragment for COX5b (the gene encoding the Vb isoform of subunit V). Because YHB1 and ACT1 mRNAs migrate to a similar position in the gel, the Nytran membranes were hybridized with the YHB1 probe and then stripped and rehybridized with the ACT1 probe. Blots were quantitated with an AMBIS Radioanalytic Imaging System.

Miscellaneous

Whole cell respiration was measured with a YSI oxygen electrode (33). Southern blots of total DNA (33) were done as described previously. Paraquat, diethylmaleate, and diamide were obtained from Sigma; 2.5% CO2 in O2-free N2 and 95% O2 plus 5% N2 were obtained from U.S. Welding (Denver, CO); and 99.5% CO was obtained from General Air Service and Supply (Denver, CO).


RESULTS

YHb Is Not Essential for Cell Growth

To determine if YHb is essential for cell growth, we constructed strains carrying a null mutation in its structural gene, YHB1 (10). This gene is located in the right arm of chromosome VII, distal to the Ade3 locus (34). As described under ``Experimental Procedures,'' the YHB1 gene was disrupted in two isochromosomal strains, JM43 and JM43rho o, that are rho+ and rhoo, respectively. The yhb1- derivatives of these strains are designated DR11 and DR10, respectively. Confirmation that the genomic copy of YHB1 was disrupted in these strains was obtained by comparing genomic Southern blots of JM43 with DR11 (Fig. 1) and JM43rho o with DR10 (not shown). Digestion of genomic DNA from either JM43 or JM43rho o with BamHI, which cuts outside of the YHB1 gene (Fig. 1A), yields a single band of about 4.6 kb (Fig. 1B). Digestion of genomic DNA from either DR11 or DR10 with BamHI yields a single band that is about 5.4 kb (Fig. 1B). This is the expected result for a YHB1 gene carrying a 1.1-kb insertion (containing the URA3 gene) and a 0.3-kb deletion.

To determine the effects of the YHB1 null mutation on cell growth, cells were grown on media containing repressing (e.g. dextrose) or nonrepressing (e.g. galactose) carbon sources. From Table I it is clear that the growth rates of the rho o+yhb1- or rho ooyhb1- strains (DR11 and DR10, respectively) were unaffected relative to their rho+YHB1+ and rhoo YHB1+ counterparts (JM43 and JM43rho o, respectively), on either carbon source. This confirms the results of a recent report that a yhb1-rho+ strain is phenotypically similar to a YHB1+rho+ strain with respect to growth on fermentable carbon sources (34). In addition, we have found that the anaerobic growth rates and cell yields for the rho+yhb1- strain (DR11) and the rho+YHB1 strain (JM43) are exactly the same.

Table I.

Comparison of the growth rates of yeast strains in YPD and YPGal


Yeast strains Mass doubling times
in YPD in YPGal

h
JM43 1.5 2.2
DR11 1.5 2.2
JM43rho o 2 3.8
DR10 1.8 3.4

The finding that the growth characteristics of YHB1 and yhb1- strains are the same may be interpreted in one of two ways. Either YHB1 is the only gene encoding a flavohemoglobin in S. cerevisiae and hence its protein product, YHb, is not essential for cell growth, or flavohemoglobins are encoded by more than one gene and when YHB1 is rendered nonfunctional a flavohemoglobin isoform of YHb, encoded by another gene, is produced and is a functional substitute for YHb. The most direct way to distinguish between these two possibilities is to examine a yhb1- strain for the presence of flavohemoglobin pigment. Insofar as the level of flavohemoglobin is extremely low in respiration-proficient strains and is elevated in respiration-deficient strains (21), the flavohemoglobin pigment is most easily observed in rhoo strains (21). When subjected to difference spectroscopy (reduced minus oxidized), JM43rho o cells reveal an absorption maximum at 561 nm, a shoulder at 551 nm, and an absorption minimum at 582 nm (Fig. 2, trace 2). The shoulder at 551 nm corresponds to reduced cytochrome c. The maximum at 561 nm and minimum at 582 nm, correspond to reduced YHb. They are similar to those for purified human hemoglobin (Fig. 2, trace 1). It is clear that DR10, the yhb1- derivative of JM43rho o, lacks these maxima and minima but retains an absorption maximum at 551 nm (Fig. 2, trace 3). This is expected for a strain that retains cytochrome c but lacks YHb. A more sensitive assay for the presence of YHb is difference spectroscopy in the presence of CO. CO difference spectroscopy of JM43rho o reveals the characteristic flavohemoglobin maximum at 440 nm as well as a minimum at 422 nm (Fig. 3, trace 1) reported earlier (21, 35). In contrast, CO difference spectroscopy of DR10 reveals the absence of a CO-binding pigment with these absorption characteristics (Fig. 3, trace 2).


Fig. 2. Absorption spectra of whole yeast cell suspensions of strains JM43rho o and DR10. Yeast cells were suspended in 0.1 M potassium phosphate buffer, pH 7.0 and either oxidized or reduced as described in ``Experimental Procedures.'' All spectra are difference spectra (reduced minus oxidized). Trace 1, difference spectrum of human hemoglobin. Trace 2, difference spectrum of strain JM43rho o. Trace 3, difference spectrum of strain DR10. The wavelengths of selected absorption maxima and minima are as indicated.
[View Larger Version of this Image (18K GIF file)]


Fig. 3. CO-ligated difference spectra of whole yeast cell suspensions of strains JM43rho o and DR10. A reduced, whole cell suspension was bubbled slowly with CO gas for 5 min. The visible/Soret spectra of the same sample were recorded before and after the exposure to CO. The base line spectrum, obtained from the difference between the two spectra of the same reduced sample, was subtracted from the reduced minus CO ligated difference spectra. Trace 1, difference spectrum of strain JM43rho o. Trace 2, difference spectrum of strain DR10.
[View Larger Version of this Image (17K GIF file)]

Together, these findings demonstrate that DR10 lacks any flavohemoglobin pigment and rule out the possibility that a YHb isoform, which could substitute for YHb, is present in DR10. This conclusion is supported by a BLAST search of the entire yeast genome; no other genes with significant similarity to YHB1 were found. Because JM43rho o and DR10 have similar growth rates on YPD and YPGal, we conclude that YHb, which is present in JM43rho o but absent in DR10, is not essential and does not affect growth rates or yields, at least under our standard laboratory conditions.

YHb Does Not Function in Respiration

To examine the possibility that YHb functions as a terminal oxidase, we measured the rates of whole cell respiration in the yhb1- mutants, DR10 and DR11 (Table II). Cyanide-sensitive and cyanide-insensitive rates were determined. In the presence and the absence of cyanide the yhb1- mutation has little if any effect on the respiration rates in the rho+ strain. This finding indicates that the YHb does not contribute to either the mitochondrial respiratory chain (i.e. cyanide-sensitive) or to cyanide-insensitive respiration by an alternative respiratory chain (36). Similar results were obtained with the rhoo strains JM43rho o and DR10. As expected, respiration in the absence of cyanide is greatly reduced because these strains lack functional mitochondrial respiratory chains. Considered together, these results clearly show that YHb is not required for respiration in vivo.

Table II.

Rates of cyanide-sensitive and cyanide-insensitive respiration


Yeast strains Respiration rate
Without cyanidea With cyanidea

nmol of O2/min/mg wet weight
JM43 11  ± 1 0.4  ± 0.1
DR11 12  ± 1 0.4  ± 0.1
JM43rho o 0.3  ± 0.05 0.3  ± 0.05
DR10 0.3  ± 0.05 0.3  ± 0.05

a  The values given are the averages and error ranges based on three samples (for strain JM43) and two samples for all other strains.

Effects of Oxygen Tension on YHB1 Transcription

In order to gain insight concerning possible functions of the YHb, we have examined the expression of its gene, YHB1. Similar studies on the expression of the Vitreoscilla hemoglobin revealed that it was expressed optimally under hypoxic conditions; these findings were among the first to suggest that this protein functions as an oxygen scavenger (3, 13, 14). In S. cerevisiae there are two classes of yeast genes: ``aerobic'' genes, which are expressed optimally in the presence of air, and ``hypoxic'' genes, which are expressed optimally at low oxygen concentrations (37, 38, 39). To examine the effects of oxygen on YHB1 expression and determine if it is an aerobic or hypoxic gene, we compared its expression with that of COX5a, an aerobic gene, and COX5b, a hypoxic gene, in cells grown through several generations in a fermentor sparged with either air, nitrogen, or 95% O2. RNA isolated from JM43 cells was subjected to Northern blot analysis using probes specific for YHB1, COX5a, the gene for the aerobic isoform (Va) of cytochrome c oxidase subunit V (40), and ACT1, the actin gene. The ACT1 gene, whose expression is not affected by oxygen, was used as a control. From Fig. 4 it is clear that the transcript levels for YHB1 are reduced in the absence of oxygen (lane 1) and slightly elevated under hyperoxic conditions (lane 3). Relative to ACT1 mRNA levels the level of YHB1 mRNA is reduced to 23% of its aerobic level in the absence of oxygen. Under hyperoxic conditions it is increased by 5-10% relative to its aerobic levels. Although small this increase is observed reproducibly in hyperoxic cells. For comparison, the relative levels of mRNA from COX5a, an aerobic yeast gene, were determined. Like YHB1, this gene is down-regulated in anaerobic cells to about 25% of its aerobic levels. However, in contrast to YHB1, the expression of COX5a in hyperoxic conditions is reduced (by 10-15%) relative to its expression in air.


Fig. 4. Expression of YHB1 mRNA at different oxygen tensions. Total RNA from yeast cells grown in nitrogen, air, or 95% oxygen was isolated and hybridized as described under ``Experimental Procedures.'' The blot was probed for YHB1 and COX5a and then stripped and reprobed for ACT1 and COX5a. Signals were quantitated with an AMBIS Radioanalytic Imaging system, and the YHB1 mRNA signal was normalized to that for ACT1 mRNA.
[View Larger Version of this Image (48K GIF file)]

To determine if YHB1 is optimally expressed at some oxygen concentration other than those used for the experiment shown in Fig. 4, we performed shift experiments. First, we shifted cells from air to nitrogen. For this experiment JM43 cells were grown up to mid-log phase in a fermentor in the presence of air, and then the sparge gas was shifted from air to nitrogen. Upon shifting cells from air to nitrogen the dissolved oxygen concentration in the fermentor fell rapidly during the first 10 min after the shift and then decreased more slowly throughout the remainder of the experiment (Fig. 5). The mRNA levels from both YHB1 and COX5a increased slightly during the first 10 min after the shift and then decreased to about 30% of their aerobic levels. COX5b, the gene for the hypoxic isoform (Vb) of cytochrome c oxidase subunit V (40), was expressed transiently at low levels between 15 and 20 min after the shift. It is expressed at higher levels in steady state anaerobic cultures (Fig. 5, lane 11). From these findings it is clear that YHB1 is optimally expressed in the presence of air and that its expression declines as cells become hypoxic. It is also clear that YHB1 mRNA levels parallel those of the aerobic gene COX5a and not the hypoxic gene COX5b.


Fig. 5. Expression of YHB1 mRNA after a shift to low oxygen. Yeast cells were grown in a fermentor to early to mid-log phase in air. At zero time, the first sample was taken, and the sparge gas was changed from air to nitrogen. Cells were harvested for RNA at different times after the shift, as follows: lane 1, 0 min; lane 2, 5 min; lane 3, 10 min; lane 4, 15 min; lane 5, 20 min; lane 6, 30 min; lane 7, 40 min; lane 8, 60 min; lane 9, 90 min; lane 10, 120 min. The blot shown in lane 11 contains RNA isolated from cells grown for 19 h in nitrogen. Total RNA was isolated and hybridized as described under ``Experimental Procedures.'' Top, blots were probed as described in the legend to Fig. 4. Bottom, the RNA's shown in the top panel were quantitated and normalized to the ACT1 mRNAs. The YHB1/ACT1 ratios are reported relative to the ratio at zero time. black-square, ratio of YHB1/ACT1 mRNAs. square , ratio of COX5a/ACT1 mRNAs.
[View Larger Version of this Image (49K GIF file)]

In a second experiment cells were shifted from air to 95% oxygen. The dissolved oxygen concentration increased rapidly during the first 5 min after the shift and then more slowly throughout the remainder of the 120-min incubation period (Fig. 6). The mRNA levels for both YHB1 and COX5a declined initially and then rose gradually to their steady state levels. When normalized to the ACT1 transcript the level of expression of YHB1 mRNA was somewhat higher (~ 20%) than the level of expression of COX5a during the majority of time the cells were exposed to hyperoxia. So, although YHB1 is expressed like an aerobic gene at oxygen concentrations between atmospheric and anaerobic, it is hyperexpressed relative to an aerobic gene under hyperoxic conditions.


Fig. 6. Expression of YHB1 mRNA after a shift to high oxygen. Yeast cells were grown in a fermentor to early to mid-log phase in air. At zero time the first sample was taken, and the sparge gas was changed from air to 95% oxygen. Cells were harvested for RNA at different times after the shift, as follows: lane 1, 0 min; lane 2, 5 min; lane 3, 10 min; lane 4, 15 min; lane 5, 20 min; lane 6, 30 min; lane 7, 40 min; lane 8, 60 min; lane 9, 90 min; lane 10, 120 min. The blot shown in lane 11 contains RNA isolated from cells grown for 16 h in 95% oxygen. Total RNA was isolated and hybridized as described under ``Experimental Procedures.'' Top, blots were probed as described in the legend to Fig. 4. Bottom, the RNAs shown in the top panel were quantitated and normalized to the ACT1 mRNAs. The YHB1/ACT1 ratios are reported relative to the ratio at zero time. black-square, ratio of YHB1/ACT1 mRNAs. square , ratio of COX5a/ACT1 mRNAs.
[View Larger Version of this Image (34K GIF file)]

Cells That Carry a yhb1- Deletion Mutation Are Sensitive to Oxidative Stress

The finding that YHB1 is hyperexpressed relative to the aerobic gene, COX5a, in hyperoxic conditions suggested a possible role for YHb in the oxidative stress response. To examine this possibility we compared the sensitivity of YHB1+ and yhb1- cells with a variety of conditions that can induce oxidative stress. Four types of conditions were used to promote oxidative stress in intact yeast cells: exposure to thiol oxidants that affect glutathione (GSH) levels in the cell, exposure to hydroperoxides, exposure to redox recyling compounds, and exposure to hyperoxia (41, 42, 43, 44). Two thiol oxidants, diamide and diethylmaleate, were used. These modify the GSH levels in the cell as follows. GSH is oxidized by diamide and is depleted by conjugation with diethylmaleate (45). Because GSH is an important antioxidant and helps maintain a reducing environment in the cell, its depletion or oxidation mimics some of the effects of oxidative challenge (46). These studies were done in the rhoo strains JM43rho o and DR10 because the level of YHb in rho+ cells is negligible (21). From Fig. 7 it is clear that yhb1- cells are more sensitive than YHB1+ cells to diethylmaleate and, to a lesser extent, diamide under aerobic conditions. In addition, growth rates of yhb1- cells are slower than YHB1+ cells when exposed to diethylmaleate and diamide. Under hyperoxic conditions both strains become more sensitive to these compounds, but the sensitivity of the yhb1- strain is more greatly enhanced than the YHB1+ strain (data not shown). Paraquat, a redox-recycling drug that generates superoxide (47), had a minor effect when added to cells in air. However, sensitivity of the yhb1- strain is greatly enhanced under hyperoxic conditions. Unlike the results obtained with the three drugs mentioned above, yhb1- cells were no more sensitive to H2O2 than YHB1+ cells when grown either in air or under hyperoxic conditions. This may be due to a high level of catalase and/or peroxidase in these yeast strains.


Fig. 7. Effects of drugs causing oxidative stress on strains JM43rho o and DR10. Log phase cultures of JM43rho o or DR10, grown in YPGal, were plated onto YPD agar containing diethylmaleate or diamide at various concentrations. The plates were incubated at 28 °C for 5 days, and the number of colonies was counted. The numbers of colonies of JM43rho o (open circle ) and DR10 (bullet ), expressed as a percentage of the control (without any drug), were plotted against the drug concentrations. The averages and standard deviations from three samples are presented.
[View Larger Version of this Image (18K GIF file)]

To confirm that the effects observed above are due to the lack of a functional YHb protein, we transformed DR10 with the pFL46s-YHB1 plasmid. From Fig. 8 it is clear that a plasmid-borne YHB1 gene is capable of partially reversing the sensitivity of the parent strain to diethylmaleate. At present, we do not know why the plasmid-borne YHB1 gene does not completely restore drug resistance to wild type levels. However, it is most likely the result of reduced expression of the plasmid-borne YHB1 gene because CO difference spectra reveal that the transformed strain contained about half of the JM43rho o level of YHb (data not shown). Because the YHB1 promoter has not been characterized yet, it is possible that the 460 bp of 5'-flanking sequence on the plasmid-borne YHB1 gene was not sufficient for maximal expression. Despite the reduced expression of YHb in DR10-pFL46s-YHB1 compared with JM43rho o, it is noteworthy that this strain was about half as resistant to diethylmaleate as JM43rho o. This finding, together with the fact that this strain contains about half of the JM43rho o level of YHb, suggests that the degree of resistance to oxidative stress parallels the intracellular level of YHb. When considered together these findings support the conclusion that YHb plays a role in the oxidative stress response in yeast.


Fig. 8. A plasmid containing YHB1 provides partial protection against oxidative stress. Strains JM43rho o, DR10, and DR10 transformed with pFL46s-YHB1 were grown to mid-log phase on selective media for the plasmid (i.e. synthetic complete liquid medium minus leucine; Ref. 59) and then plated onto agar plates made up with the same selective medium but containing diethylmaleate at various concentrations. The plates were incubated at 28 °C for 5 days, and the number of colonies was counted. The number of colonies, expressed as a percentage of the control (without drug), are plotted against the diethylmaleate concentration. The averages and standard deviations from three samples are shown. open circle , strain JM43rho o; bullet , strain DR10; ×, strain DR10 + pFL46s-YHB1.
[View Larger Version of this Image (22K GIF file)]

YHB1 Transcription Is Up-regulated under Conditions of Oxidative Stress

Many genes that encode proteins that function as antioxidants or participate in oxidative stress response pathways are induced in cells that are exposed to reagents that promote oxidative stress (43, 44, 48). To determine if YHB1 expression is affected in a similar manner, RNA isolated from cells treated with diethylmaleate, diamide, paraquat, and hydrogen peroxide were subjected to Northern analysis (Fig. 9). Northern analysis was also performed on RNA isolated from cells treated with antimycin A, which enhances the production of reactive oxygen species (ROS) by inhibiting complex III of the mitochondrial electron transport chain and which has been shown previously to increase intracellular levels of YHb (10, 22). Using the ACT1 gene as a control, we have found that H2O2, diamide, and diethylmaleate all enhance expression of YHB1 by 1.5-2-fold within 1 h after exposure. The level of YHB1 expression in antimycin A-treated cells is enhanced nearly 3-fold. In contrast, paraquat had no effect. Because the level of superoxide produced in the presence of paraquat may be kept low by the cell's cytosolic and mitochondrial superoxide dismutases (encoded by the SOD1 and SOD2 genes, respectively; Ref. 24), we examined YHB1 expression in an sod1-sod2- strain. From Fig. 10 it is clear that YHB1 expression is elevated about 3-fold in an sod1-sod2- strain, relative to the SOD1+SOD2+ parent. Thus, it is likely that superoxide as well as other ROS can participate in the up-regulation of YHB1.


Fig. 9. YHB transcription in JM43 in response to oxidative stress. Strain JM43 was grown in YPGal medium to mid-log phase and pelleted. Cells were resuspended in an equal volume of YPGal containing the following additions: no drug control (lane 1), 1 mM paraquat (lane 2), 1 mM H2O2 (lane 3), 1.5 mM diamide (lane 4), 2 mM diethylmaleate (lane 5), and 3 mg antimycin A/liter of culture (lane 6). Strain DR11 was used as a yhb1- control and is shown in lane 7. After resuspension all cells were incubated at 28 °C for 1 h. Total RNA was prepared and blotted with probes for either the YHB1 or ACT1 genes, as described under ``Experimental Procedures.'' The YHB1/ACT1 ratios were obtained by AMBIS quantiation.
[View Larger Version of this Image (33K GIF file)]


Fig. 10. Up-regulation of YHB1 in a superoxide dismutase deficient strain. Northern blot analysis of a sod1-sod2- mutant (EG133) and its parent strain (EG103). Total RNA was prepared from both strains and blotted with both YHB1 and ACT1 probes as described under ``Experimental Procedures.'' The YHB1/ACT1 ratios were determined by AMBIS quantiation.
[View Larger Version of this Image (42K GIF file)]


DISCUSSION

The results presented here address the in vivo function of the YHb flavohemoglobin of S. cerevisiae. They indicate that this protein participates in the oxidative stress response and probably does not function as an alternative oxidase or in oxygen delivery.

YHb Is Not Required For Respiration or Alternative Oxidase Activity in Vivo

Several previous papers have speculated that microbial hemoglobins may function as terminal or alternative oxidases (1, 2, 10, 15). The most compelling evidence for this comes from studies with Vitreoscilla hemoglobin. This protein is expressed optimally under microaerophilic conditions (49) and enhances cell growth under oxygen-limiting conditions when overexpressed in E. coli (14). Moreover, this hemoglobin is capable of rescuing terminal oxidase mutants of E. coli (15). S. cerevisiae and other fungi have an alternative respiratory pathway, which is distinquishable from the mitochondrial respiratory pathway by its insensitivity to cyanide (36). To examine the possibility that YHb functions as an alternative terminal oxidase in this pathway, we examined the rates of respiration in YHB1+ and yhb1- cells. We found no difference in the rates of cyanide-sensitive or insensitive respiration in these strains, indicating that YHb does not function in vivo either in mitochondrial respiration or in a cyanide-insensitive alternative respiratory pathway. This conclusion is supported by the results of previous studies with the hemoglobins of the yeasts Candida (35) and S. cerevisiae (19, 20). Early studies on the physiological function of Candida hemoglobin demonstrated that it could be destroyed in vivo by exposing cells to ethyl hydrogen peroxide and that destruction of the hemoglobin pigment had no effect on cell growth or respiration (35). More recently, Zhu and co-workers (19, 20) found that purified YHb has NAD(P)H-dependent reductase activity, binds oxygen reversibly only when NAD(P)H is present, and does not oxidize reduced cytochrome c. Together with our findings these results indicate that YHb is not essential for and does not have oxidase activity. Of course, it is possible that YHb might be able to reduce oxygen under some conditions.

YHb Probably Does Not Function in Oxygen Storage and/or Diffusion

Previous attempts to ask if microbial hemoglobins function in oxygen storage or diffusion have relied on measuring their levels of expression in cells grown at different oxygen concentrations. Hemoglobin levels in both Vitreoscilla and A. eutrophus increase in cells grown under hypoxic conditions (7, 49). These findings, together with the observation that overproduction of Vitreoscilla hemoglobin in E. coli allows cells to grow to higher cell densities (14) has been used as evidence in support of a role for this protein in oxygen transport and diffusion. Our findings that yhb1- cells grow as well as YHB1+ cells both under normoxic and hypoxic conditions and that yhb1- cells and YHB1+ cells have comparable levels of respiration argue against an essential role for YHb in oxygen delivery in yeast cells. Moreover, unlike the hemoglobins of Vitreoscilla and A. eutrophus, YHb is optimally expressed in yeast cells grown in air or under hyperoxic conditions (Ref. 34 and this study).

A Role for YHb in the Oxidative Stress Response

A role for YHb in the oxidative stress response in yeast is suggested by two lines of evidence: conditions that promote oxidative stress in yeast enhance expression of YHB1, and yhb1- mutant cells are more sensitive to oxidative stress than YHB1+ cells. Under normoxic conditions the intracellular levels of YHb are low. However, YHb levels increase in cells treated with antimycin A or cyanide (10, 22). These reagents inhibit the terminal steps in mitochondrial electron transport and stimulate the production and release of ROS (50, 51). In this study, we have found that at least part of this increase in YHb levels occurs at the level of transcription. Antimycin A increases YHB1 mRNA levels nearly 3-fold. In addition, we have found that YHB1 mRNA levels are up-regulated under hyperoxic conditions and in mutant cells that lack mitochondrial and cytosolic superoxide dismutases. Because a common factor in all of these conditions is the generation of ROS these findings suggest that ROS serve as signals that up-regulate YHB1. Currently, it is not clear how ROS up-regulate YHB1 and whether this up-regulation occurs at the level of transcriptional initiation or transcript stability. However, YAP1p, which belongs to the AP-1 family of eucaryotic transcription factors (52), may be involved because there are AP-1 consensus binding sites in the YHB1 promoter and because YAP1-dependent transcription in yeast is induced by treating cells with some of the same thiol oxidants (e.g. diamide and diethylmaleate) that induce expression of YHB1 (43).

During aerobic respiration molecular oxygen is generally reduced by four electrons to water. However, a small percentage of the oxygen consumed during respiration is not completely reduced to water but instead is only partially reduced to the highly reactive intermediates, superoxide (Obardot 2), hydrogen peroxide (H2O2), and the hydroxyl ion (OHdot ) (53). These partially reduced forms of oxygen, i.e. ROS, are also produced independently of respiration during oxygen consuming reactions in the cytosol. ROS are highly unstable reactive compounds that have been shown to mutate DNA (54), oxidize proteins (55), and damage membranes (56). All aerobic organisms have evolved antioxidant defense systems to help keep the harmful effects of ROS in check. In this study, we have exposed cells to a number of conditions that generate oxidative stress and analyzed the antioxidant capacity of S. cerevisiae cells that lack a functional YHB1 gene. Diethylmaleate and diamide treatment reduce the levels of intracellular GSH either by forming GSH conjugates via glutathione S-transferase or by oxidizing it to GSSG. The ability of yeast cells to survive exposure to these chemicals is dependent on a functional YHB1 gene. Yeast cells that lack a YHB1 gene are also more sensitive to growth in hyperoxic conditions than cells that carry a functional YHB1 gene. Importantly, each of these conditions also enhance the level of expression of YHB1. Together, these results imply that YHb plays a role in the response of yeast cells to oxidative stress.

Currently, it is possible to envision at least two roles for YHb in the oxidative stress response. It may function as an antioxidant itself or it may participate in a sensing pathway that responds to oxidative stress. As a flavohemoprotein YHb may bind ROS and reduce them to water by a mechanism that is analogous to the reduction of oxygen to water by cytochrome c oxidase (57). For example, it is plausible that superoxide can bind to the Fe2+ form of heme to produce the peroxy derivative (Fe3+-O--O-) or that H2O2 binds to the peroxy form to give the Fe3+-O--OH derivative. From the recent findings that YHb has NAD(P)H reductase activity and can transfer electrons from NAD(P)H to its heme iron (19, 20) and that YHb has a high rate of autooxidation, it is plausible that either the Fe3+-O--O- or the Fe3+-O--OH derivative can then be reduced to water by electrons supplied from NAD(P)H. Alternatively, YHb may bind ROS and, as such, serve as a proximal sensor for oxidative stress. In this regard it is noteworthy that HMP, the E. coli counterpart of YHb, has been proposed as an oxygen sensor (17, 18). Because the level of ROS produced is proportional to the partial oxygen pressure (58) perhaps HMP and, by extension, YHb sense oxygen indirectly via the ROS produced from it. Further study with purified YHb is required to examine these possibilities and determine the precise role of this protein in the oxidative stress response in yeast.


FOOTNOTES

*   This research was supported by Grants GM39324 and GM30228 from the National Institutes of Health (to R. O. P.) and postdoctoral fellowships (to X.-J. Z. and K. E. K.) from the American Heart Association of Colorado. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Present address: Blood Research Institute, Milwaukee, WI 53226.
§   Present address: National Institute For Medical Research, Mill Hill, London, United Kingdom NW7 1AA.
   Present address: Stanford University Medical School, Stanford, CA 94305.
par    To whom correspondence should be addressed. Tel.: 303-492-3823; Fax: 303-492-7744.
1   The abbreviations used are: kb, kilobase pair(s); bp, base pair(s); GSH, glutathione; ROS, reactive oxygen species.

Acknowledgments

We thank Dr. Austen Riggs for providing the YHB1 gene, Dr. Winslow Caughey for fruitful discussion, and Sandra Pepperl for technical assistance.


REFERENCES

  1. Wittenberg, J. B., Wittenberg, B. A. (1990) Annu. Rev. Biophys. Chem. 19, 217-241 [CrossRef][Medline] [Order article via Infotrieve]
  2. Riggs, A. F. (1991) Am. Zool. 31, 535-545
  3. Wakabayashi, S., Matsubara, H., Webster, D. A. (1986) Nature 322, 481-483 [CrossRef][Medline] [Order article via Infotrieve]
  4. Vasudevan, S. G., Armarego, W. L. F., Shaw, D. C., Lilley, P. E., Dixon, N. E., Poole, R. K. (1991) Mol. & Gen. Genet. 226, 49-58 [CrossRef][Medline] [Order article via Infotrieve]
  5. Andrews, S. C., Shipley, D., Keen, J. N., Findlay, J. B. C., Harrison, P. M., Guest, J. R. (1992) FEBS Lett. 302, 247-252 [CrossRef][Medline] [Order article via Infotrieve]
  6. Ioannidis, I., Cooper, C. E., Poole, R. K. (1992) Biochem. J. 288, 649-655
  7. Probst, I., Wolf, G., Shlegel, H. G. (1979) Biochim. Biophys. Acta 576, 471-478 [Medline] [Order article via Infotrieve]
  8. Iwaasa, H., Takagi, T., Shikama, K. (1992) J. Mol. Biol. 227, 948-954 [CrossRef][Medline] [Order article via Infotrieve]
  9. Keilin, D. (1953) Nature 172, 390-393 [CrossRef][Medline] [Order article via Infotrieve]
  10. Zhu, H., Riggs, A. F. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5015-5019 [Abstract/Free Full Text]
  11. Karplus, P. A., Bruns, C. M. (1994) J. Bioenerg. Biomembr. 26, 89-99 [CrossRef][Medline] [Order article via Infotrieve]
  12. Takagi, T. (1993) Curr. Opin. Struct. Biol. 3, 413-418
  13. Perutz, M. F. (1986) Nature 322, 405 [CrossRef]
  14. Khosla, C., Bailey, J. (1988) Nature 331, 633-635 [CrossRef][Medline] [Order article via Infotrieve]
  15. Dikshit, R. P., Dikshit, K. L., Liu, Y., Webster, D. A. (1992) Arch. Biochem. Biophys. 293, 241-245 [CrossRef][Medline] [Order article via Infotrieve]
  16. Cramm, R., Siddiqui, R. A., Friedrich, B. (1994) J. Biol. Chem. 269, 7349-7354 [Abstract/Free Full Text]
  17. Poole, R. K., Ioannidis, N, Orii, Y. (1994) Proc. R. Soc. Lond. B Biol. Sci. 255, 251-258 [Medline] [Order article via Infotrieve]
  18. Poole, R. K. (1994) Antonie Leeuwenhoek 65, 289-310 [CrossRef][Medline] [Order article via Infotrieve]
  19. Zhu, H., Olson, J. S., Riggs, A. F. (1994) FASEB J. 8, A142 (abstr. 945)
  20. Zhu, H. (1995) Yeast Flavohemoglobin: Structural and Functional Studies. Ph.D. dissertation, University of Texas, Austin, TX
  21. Waterland, R. A., Basu, A., Chance, B., Poyton, R. O. (1991) J. Biol. Chem. 266, 4180-4186 [Abstract/Free Full Text]
  22. Ycas, M. (1956) Exp. Cell. Res. 11, 1-6 [CrossRef][Medline] [Order article via Infotrieve]
  23. McEwen, J. E., Cameron, V. L., Poyton, R. O. (1985) J. Bacteriol. 161, 831-835 [Abstract/Free Full Text]
  24. Liu, X. F., Elashvili, I., Gralla, E. B., Valentine, J. S., Lapinskas, P., Culotta, V. C. (1992) J. Biol. Chem. 267, 18298-18302 [Abstract/Free Full Text]
  25. Rothstein, R. J. (1983) Methods Enzymol. 101, 202-211 [Medline] [Order article via Infotrieve]
  26. Bolivar, F., Rodrigriez, R. L., Greene, P. J., Betlach, M. C., Heynecker, H. L., Boyer, H. W., Crosa, J. H., Falkow, S. (1977) Gene (Amst.) 2, 95-113 [Medline] [Order article via Infotrieve]
  27. Botstein, D., Falco, S. C., Stewart, S. E., Brennan, M., Scherer, S., Stinchcomb, D. T., Struhl, K., Davis, R. W. (1979) Gene (Amst.) 8, 17-24 [CrossRef][Medline] [Order article via Infotrieve]
  28. Ito, H., Fukada, Y., Murata, K., Kimura, A. (1983) J. Bacteriol. 153, 163-168 [Abstract/Free Full Text]
  29. Bonneau, N., Ozier-Kalogeropoulo, O., Li, G., Labouesse, M., Minvielle-Sebastia, L., Lacroute, F. (1991) Yeast 7, 609-615 [CrossRef][Medline] [Order article via Infotrieve]
  30. Elder, R. T., Loh, E. Y., Davis, R. W. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 2432-2436 [Abstract/Free Full Text]
  31. Tsang, S. S., Yiu, X., Guzzo-Arkuran, C., Jones, V. S., Davison, A. J. (1993) BioTechniques 14, 380-381 [Medline] [Order article via Infotrieve]
  32. Sambrook, J., Fritsch, E. F., Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , p. 10.14, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  33. Cumsky, M. G., Ko, C., Trueblood, C. E., Poyton, R. O. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 2235-2239 [Abstract/Free Full Text]
  34. Crawford, M. J., Sherman, D. R., Goldberg, D. E. (1995) J. Biol. Chem. 270, 6991-6996 [Abstract/Free Full Text]
  35. Oshino, R., Oshino, N., Chance, B, Hagihara, B. (1973) Eur. J. Biochem. 35, 23-33 [Medline] [Order article via Infotrieve]
  36. Guerin, B. (1991) The Yeasts (Rose, A. H., Harrison, J. S., eds) , p. 541, Academic Press, Orlando, FL
  37. Zitomer, R. S., Lowry, C. V. (1992) Microbiol. Rev. 56, 1-11 [Abstract/Free Full Text]
  38. Poyton, R. O., Burke, P. V. (1992) Biochim. Biophys. Acta. 1101, 252-256 [Medline] [Order article via Infotrieve]
  39. Bunn, H. F., Poyton, R. O. (1996) Physiol. Rev. 76, 839-885 [Abstract/Free Full Text]
  40. Poyton, R. O., Trueblood, C. E., Wright, R. M., Farrel, L. E. (1988) Ann. N. Y. Acad. Sci. 550, 229-307
  41. Sies, H. (1985) Oxidative Stress (Sies, H., eds) , p. 73, Academic Press, Orlando, FL
  42. Plummer, J. L., Smith, B. R., Sies, H., Bend, J. R. (1981) Methods Enzymol. 77, 30-39
  43. Kuge, S., Jones, N. (1994) EMBO J. 13, 655-664 [Medline] [Order article via Infotrieve]
  44. Guidot, D. M., McCord, J. M., Wright, R. M., Repine, J. E. (1993) J. Biol. Chem. 268, 26699-26703 [Abstract/Free Full Text]
  45. Boyland, E., Chasseaud, L. F. (1967) Biochem. J. 104, 95-102 [Medline] [Order article via Infotrieve]
  46. Meister, A. (1988) J. Biol. Chem. 263, 17205-17208 [Free Full Text]
  47. Zeigler, D. M. (1987) Oxygen Free Radicals in Biology and Medicine (Simic, M. G., eds) , p. 730, Plenum Publishing Corp., New York
  48. Wu, A.-L., Moye-Rowly, W. S. (1994) Mol. Cell. Biol. 14, 5832-5839 [Abstract/Free Full Text]
  49. Boerman, S. J., Webster, D. A. (1982) J. Gen. Appl. Microbiol. 28, 35-43
  50. Bandy, B., Davidson, A. J. (1990) Free Radical Biol. & Med. 8, 523-539 [CrossRef][Medline] [Order article via Infotrieve]
  51. Poyton, R. O., McEwen, J. E. (1996) Annu. Rev. Biochem. 65, 563-607 [CrossRef][Medline] [Order article via Infotrieve]
  52. Angel, P, Karin, M. (1991) Biochim. Biophys. Acta 1072, 129-157 [Medline] [Order article via Infotrieve]
  53. Cadenas, E. (1989) Annu. Rev. Biochem. 58, 79-110 [CrossRef][Medline] [Order article via Infotrieve]
  54. Ames, B. N., Shigenaga, M. K., Hagen, T. M. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 7915-7922 [Abstract/Free Full Text]
  55. Statdman, E. R. (1992) Science. 257, 1220-1224 [Abstract/Free Full Text]
  56. Yu, B. P. (1993) Free Radicals and Aging (Yu, B. P., eds) , p. 57, CRC Press, Inc., Boca Raton, FL
  57. Babcock, G. T., Wikstrom, M. (1992) Nature 356, 301-309 [CrossRef][Medline] [Order article via Infotrieve]
  58. Boveris, A. (1977) Tissue Hypoxia and Ischemia (Reivich, M., Coburn, R., Lahiri, S., Chance, B., eds) , p. 67, Plenum Publishing Corp., New York
  59. Sherman, F. (1991) Methods Enzymol. 194, 3-21 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
P. R. Castello, D. K. Woo, K. Ball, J. Wojcik, L. Liu, and R. O. Poyton
Reactive Oxygen Species Special Feature: Oxygen-regulated isoforms of cytochrome c oxidase have differential effects on its nitric oxide production and on hypoxic signaling
PNAS, June 17, 2008; 105(24): 8203 - 8208.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Godecke
On the impact of NO-globin interactions in the cardiovascular system
Cardiovasc Res, February 1, 2006; 69(2): 309 - 317.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Gonzalez-Cabo, R. P. Vazquez-Manrique, M. A. Garcia-Gimeno, P. Sanz, and F. Palau
Frataxin interacts functionally with mitochondrial electron transport chain proteins
Hum. Mol. Genet., August 1, 2005; 14(15): 2091 - 2098.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Cassanova, K. M. O'Brien, B. T. Stahl, T. McClure, and R. O. Poyton
Yeast Flavohemoglobin, a Nitric Oxide Oxidoreductase, Is Located in Both the Cytosol and the Mitochondrial Matrix: EFFECTS OF RESPIRATION, ANOXIA, AND THE MITOCHONDRIAL GENOME ON ITS INTRACELLULAR LEVEL AND DISTRIBUTION
J. Biol. Chem., March 4, 2005; 280(9): 7645 - 7653.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
T. Hon, H. C. Lee, Z. Hu, V. R. Iyer, and L. Zhang
The Heme Activator Protein Hap1 Represses Transcription by a Heme-Independent Mechanism in Saccharomyces cerevisiae
Genetics, March 1, 2005; 169(3): 1343 - 1352.
[Abstract] [Full Text] [PDF]